Matches in SemOpenAlex for { <https://semopenalex.org/work/W2887372012> ?p ?o ?g. }
Showing items 1 to 80 of
80
with 100 items per page.
- W2887372012 abstract "Infliximab infusion generally occurs in 2-4 h. Recent studies have suggested the possibility of accelerated infusion (1 h) of this drug.To evaluate the safety of accelerated infliximab infusion in patients with rheumatic diseases. In addition, patient satisfaction was also assessed.A prospective, single-center, non-randomized study with 34 patients with rheumatic diseases was conducted from July to November 2016. Patients with the following were excluded: history of allergic reaction to biologics, asthma or severe atopy. All patients previously received a 2- to 3-h infliximab infusion. The infusion rate was accelerated to 1 h, and premedication was excluded. The infusion was monitored in all patients.A total of 34 patients were included in the study [rheumatoid arthritis (n = 16), ankylosing spondylitis (n = 15), psoriatic arthritis (n = 2) and enteropathic arthropathy (n = 1)], with an average age of 48.7 ± 18.6 years; 55.5% of the patients were female, and 29.4% were white. The duration of disease was 9.5 ± 9.2 years, and the duration of infliximab use was 38.9 ± 27.6 months, with a mean dose per infusion of 414.2 ± 158.1 (range, 200-800) mg. The mean infliximab infusion time prior to the study was 2.2 ± 0.4 h. A total of 6 (17.6%) patients received premedication. The premedication was suspended. There were no adverse effects during or after infusion. Ninety-seven percent of the patients and 100% of the health workers were satisfied with the accelerated infusion.Our data support the safe use of accelerated infliximab infusion in rheumatic patients, with high satisfaction among patients and health workers." @default.
- W2887372012 created "2018-08-22" @default.
- W2887372012 creator A5002347357 @default.
- W2887372012 creator A5022541194 @default.
- W2887372012 creator A5038013979 @default.
- W2887372012 creator A5042820748 @default.
- W2887372012 creator A5080024989 @default.
- W2887372012 creator A5090623812 @default.
- W2887372012 date "2018-08-03" @default.
- W2887372012 modified "2023-10-06" @default.
- W2887372012 title "Evaluation of the safety and satisfaction of rheumatic patients with accelerated infliximab infusion" @default.
- W2887372012 cites W1554962003 @default.
- W2887372012 cites W1988250561 @default.
- W2887372012 cites W2012597670 @default.
- W2887372012 cites W2026882851 @default.
- W2887372012 cites W2035554099 @default.
- W2887372012 cites W2037976962 @default.
- W2887372012 cites W2093372305 @default.
- W2887372012 cites W2134645375 @default.
- W2887372012 cites W2152348310 @default.
- W2887372012 cites W2158921110 @default.
- W2887372012 cites W4211046919 @default.
- W2887372012 doi "https://doi.org/10.1186/s42358-018-0016-x" @default.
- W2887372012 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/30657070" @default.
- W2887372012 hasPublicationYear "2018" @default.
- W2887372012 type Work @default.
- W2887372012 sameAs 2887372012 @default.
- W2887372012 citedByCount "1" @default.
- W2887372012 countsByYear W28873720122021 @default.
- W2887372012 crossrefType "journal-article" @default.
- W2887372012 hasAuthorship W2887372012A5002347357 @default.
- W2887372012 hasAuthorship W2887372012A5022541194 @default.
- W2887372012 hasAuthorship W2887372012A5038013979 @default.
- W2887372012 hasAuthorship W2887372012A5042820748 @default.
- W2887372012 hasAuthorship W2887372012A5080024989 @default.
- W2887372012 hasAuthorship W2887372012A5090623812 @default.
- W2887372012 hasBestOaLocation W28873720121 @default.
- W2887372012 hasConcept C126322002 @default.
- W2887372012 hasConcept C141071460 @default.
- W2887372012 hasConcept C197934379 @default.
- W2887372012 hasConcept C2776260265 @default.
- W2887372012 hasConcept C2777138892 @default.
- W2887372012 hasConcept C2777402515 @default.
- W2887372012 hasConcept C2777575956 @default.
- W2887372012 hasConcept C2778300832 @default.
- W2887372012 hasConcept C2779134260 @default.
- W2887372012 hasConcept C2780402116 @default.
- W2887372012 hasConcept C42219234 @default.
- W2887372012 hasConcept C71924100 @default.
- W2887372012 hasConceptScore W2887372012C126322002 @default.
- W2887372012 hasConceptScore W2887372012C141071460 @default.
- W2887372012 hasConceptScore W2887372012C197934379 @default.
- W2887372012 hasConceptScore W2887372012C2776260265 @default.
- W2887372012 hasConceptScore W2887372012C2777138892 @default.
- W2887372012 hasConceptScore W2887372012C2777402515 @default.
- W2887372012 hasConceptScore W2887372012C2777575956 @default.
- W2887372012 hasConceptScore W2887372012C2778300832 @default.
- W2887372012 hasConceptScore W2887372012C2779134260 @default.
- W2887372012 hasConceptScore W2887372012C2780402116 @default.
- W2887372012 hasConceptScore W2887372012C42219234 @default.
- W2887372012 hasConceptScore W2887372012C71924100 @default.
- W2887372012 hasLocation W28873720121 @default.
- W2887372012 hasLocation W28873720122 @default.
- W2887372012 hasLocation W28873720123 @default.
- W2887372012 hasOpenAccess W2887372012 @default.
- W2887372012 hasPrimaryLocation W28873720121 @default.
- W2887372012 hasRelatedWork W1505374175 @default.
- W2887372012 hasRelatedWork W1539773147 @default.
- W2887372012 hasRelatedWork W2013915797 @default.
- W2887372012 hasRelatedWork W2075378263 @default.
- W2887372012 hasRelatedWork W2076047408 @default.
- W2887372012 hasRelatedWork W2087248190 @default.
- W2887372012 hasRelatedWork W2103766756 @default.
- W2887372012 hasRelatedWork W2157626067 @default.
- W2887372012 hasRelatedWork W2171255147 @default.
- W2887372012 hasRelatedWork W2554846070 @default.
- W2887372012 isParatext "false" @default.
- W2887372012 isRetracted "false" @default.
- W2887372012 magId "2887372012" @default.
- W2887372012 workType "article" @default.